Enzyme therapy and immune response in relation to CRIM status: the Dutch experience in classic infantile Pompe disease

Lignende værker

• Antibody formation to enzyme therapy in classic infantile Pompe disease: implications of patient age
  af: van Gelder, C, et al.
  Udgivet: (2013)
• A higher dose of enzyme therapy in patients with classic infantile Pompe disease seems to improve ventilator-free survival and motor function
  af: van Gelder, C, et al.
  Udgivet: (2013)
• Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in classic-infantile patients with Pompe disease
  af: Kanters, Tim A, et al.
  Udgivet: (2014)
• Effects of a higher dose of alglucosidase alfa on ventilator-free survival and motor outcome in classic infantile Pompe disease: an open-label single-center study
  af: van Gelder, C. M., et al.
  Udgivet: (2016)
• Impact of enzyme replacement therapy on survival in adults with Pompe disease
  af: Güngör, Deniz, et al.
  Udgivet: (2013)